PR

CUBEBIO’s Latest News

press

Press Releases

Number Title Writer Date Hit File
61 [2024.05.03] CUBEBIO Co., Ltd. signed term sheets worth KRW 850 billion with Mountain Crest Acquisition Corp. V, a NASDAQ-listed SPAC company in the U.S. cubebio 2024-05-03 748
60 [2024.04.01] CUBEBIO Co., Ltd. signs a USD 14.8Mn-worth exclusive distribution agreement for cancer screening products with the Taiwanese pharmaceutical group Taiwan Biotech Co., Ltd. cubebio 2024-04-01 1699
59 [2024.01.22] CUBEBIO Co., Ltd. signed NASDAQ SPAC listing agreement cubebio 2024-01-22 10239
58 [2023.09.21] CUBEBIO Co., Ltd. Attracts Investment of $46.7Mn through Technology Verification .. One step forward for US Market entry cubebio 2023-09-21 14581
57 [2023.05.19] CUBEBIO's urine-based cancer screening product selected as the 'Innovative product' in Scouter Demo-day run by Public Procurement Service(PPS) cubebio 2023-05-19 16036
56 [2022.02.17] CUBEBIO, selected as the new resident company at the Healthcare Innovation Park (HIP) of Seoul National University Hospital cubebio 2022-02-17 18440
55 [2022.01.06] CUBEBIO & SNUH - Joint Technological Development for urine-based cancer diagnostics cubebio 2022-01-06 19313
54 [2021.05.21] CUBEBIO, in tandem with global demands for cancer diagnostics signed a service agreement for mass production with COSMAX PHARMA. cubebio 2021-05-21 44080
53 [2021.01.12] CUBEBIO participates in AFF, the largest financial forum in Asia. cubebio 2021-01-12 12000
52 [2021.01.07] CUBEBIO's BioHealthcare department introduces respiratory-related dietary supplement cubebio 2021-01-07 11257